Our Vision &
Investment Opportunity
We are actively seeking investment to launch our initial Pneumatic Trabeculoplasty (PNT) clinic in London, England.
At Sunridge International, we believe Pneumatic Trabeculoplasty (PNT) has the potential to transform glaucoma care worldwide. Our vision is to make this non-invasive, cost-effective, and clinically validated treatment accessible to patients across all socioeconomic levels—beginning with the launch of our first dedicated clinic in London.
London has been strategically selected as the starting point due to its diverse population, healthcare infrastructure, and the high prevalence of glaucoma. With over 700,000 glaucoma sufferers in the UK—many of whom reside in the Greater London area—the region is ideally positioned to support multiple PNT clinics. Our initial clinic will be available exclusively to the first 2,000 patients, offering early access to this advanced treatment under a carefully managed rollout.​
To bring this vision to life, we are actively seeking investment to fund the launch of the London clinic. The success of this flagship location will serve as the foundation for our wider expansion plan: establishing several clinics across the Greater London area to meet increasing demand.
Giving Back
Aligned with our commitment to global health equity, a portion of our future profits will be allocated to providing PNT at no cost in underdeveloped and remote communities around the world—ensuring access to sight-saving care where it’s needed most.
